clofilium has been researched along with Acute Promyelocytic Leukemia in 1 studies
clofilium: RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, BY | 1 |
| Kim, HY | 1 |
| Lee, KH | 1 |
| Cho, YH | 1 |
| Kong, G | 1 |
1 other study available for clofilium and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Division; DNA Fragmentation; Enzyme | 1999 |